Cargando…

Identification of covalent active site inhibitors of dengue virus protease

Dengue virus (DENV) protease is an attractive target for drug development; however, no compounds have reached clinical development to date. In this study, we utilized a potent West Nile virus protease inhibitor of the pyrazole ester derivative class as a chemical starting point for DENV protease dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koh-Stenta, Xiaoying, Joy, Joma, Wang, Si Fang, Kwek, Perlyn Zekui, Wee, John Liang Kuan, Wan, Kah Fei, Gayen, Shovanlal, Chen, Angela Shuyi, Kang, CongBao, Lee, May Ann, Poulsen, Anders, Vasudevan, Subhash G, Hill, Jeffrey, Nacro, Kassoum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677662/ https://www.ncbi.nlm.nih.gov/pubmed/26677315 http://dx.doi.org/10.2147/DDDT.S94207

Ejemplares similares

Expression and purification of the p75 neurotrophin receptor transmembrane domain using a ketosteroid isomerase tag
por: Li, Qingxin, et al.
Publicado: (2012)

Structure of the C-terminal Region of the Frizzled Receptor 1 in Detergent Micelles
por: Gayen, Shovanlal, et al.
Publicado: (2013)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
por: Amin, Sk Abdul, et al.
Publicado: (2021)

Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Investigation of the Detailed Internal Structure and Dynamics of Itraconazole by Solid-State NMR Measurements
por: Dey, Krishna Kishor, et al.
Publicado: (2019)

Understanding the correlation between structure and dynamics of clocortolone pivalate by solid state NMR measurement
por: Dey, Krishna Kishor, et al.
Publicado: (2020)

An atomic resolution description of folic acid using solid state NMR measurements
por: Ghosh, Manasi, et al.
Publicado: (2020)

Structures and Dynamics of Dengue Virus Nonstructural Membrane Proteins
por: Li, Qingxin, et al.
Publicado: (2022)

Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design
por: Li, Qingxin, et al.
Publicado: (2021)

Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies
por: Li, Qingxin, et al.
Publicado: (2020)

Dengue virus NS4B protein as a target for developing antivirals
por: Li, Qingxin, et al.
Publicado: (2022)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Boroleucine‐Derived Covalent Inhibitors of the ZIKV Protease
por: Braun, Niklas J., et al.
Publicado: (2022)

Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
por: Li, Qingxin, et al.
Publicado: (2020)

Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease
por: Tan, Yong Wah, et al.
Publicado: (2016)

Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017)

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
por: Delre, Pietro, et al.
Publicado: (2020)

Positive epistasis between viral polymerase and the 3′ untranslated region of its genome reveals the epidemiologic fitness of dengue virus
por: Syenina, Ayesa, et al.
Publicado: (2020)

Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
por: Yau, Clement, et al.
Publicado: (2020)

Development and Evaluation of an Enzyme-Linked Immunosorbent Assay for Dengue Capsid
por: Selvarajah, Suganya, et al.
Publicado: (2012)

Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group
por: Hartman, Kinga, et al.
Publicado: (2020)

Dengue virus serotype infection specifies the activation of the unfolded protein response
por: Umareddy, Indira, et al.
Publicado: (2007)

A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
por: Kathman, Stefan G., et al.
Publicado: (2014)

Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics
por: Klein, Philipp, et al.
Publicado: (2020)

Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
por: Nemukhin, A. V., et al.
Publicado: (2022)

Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin
por: Ishfaq, Pir Mohammad, et al.
Publicado: (2022)

Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat
por: Sun, Gaohui, et al.
Publicado: (2021)

Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide
por: Yamane, Daiki, et al.
Publicado: (2022)

Evolution of protease activation and specificity via alpha-2-macroglobulin-mediated covalent capture
por: Knyphausen, Philipp, et al.
Publicado: (2023)

Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2
por: Sanders, Brian, et al.
Publicado: (2022)

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
por: Kneller, Daniel W., et al.
Publicado: (2022)

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022)

Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease
por: Hognon, Cécilia, et al.
Publicado: (2022)

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2
por: Sanders, Brian, et al.
Publicado: (2022)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vjnka2kkn63m906hrpg0kdkso9